Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal.
Article
in English
| IMSEAR
| ID: sea-46529
ABSTRACT
BACKGROUND:
PZA, INH and R have potential for hepatotoxic side effects. Although anti-tuberculosis drug-induced hepatotoxicity is well known, there is no agreement on the clinical approach for cases in whom hepatotoxicity has developed.OBJECTIVE:
To study the management of anti-TB drugs induced hepatotoxicity and the standard anti-TB drugs therapy reintroduction procedure.DESIGN:
In prospective cohort analysis, 4 patients with active TB infection had developed anti-TB drugs induced hepatotoxicity. Retreatment of therapy was done on the basis of severity of hepatitis. If damage is mild, all the drugs were reintroduced at once in a tapering dose and if patient's condition is worse, INH and E is introduced in lower dose, later increasing the dose and the number of drugs.Results:
All the patients tolerated anti-TB drugs well after reintroduction. There was no incidence of recurrence. All the patients completed their 8 months treatment regimen and all are cured.CONCLUSION:
Timely detection and temporary withdrawal of the offending agent can completely cure anti-TB drugs induced hepatotoxicity. The recurrence of hepatotoxicity is rare if reintroduction in done in a well planned manner.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Tuberculosis
/
Female
/
Humans
/
Male
/
Prospective Studies
/
Adolescent
/
Adult
/
Dose-Response Relationship, Drug
/
Chemical and Drug Induced Liver Injury
/
Middle Aged
Type of study:
Observational study
Country/Region as subject:
Asia
Language:
English
Year:
2005
Type:
Article
Similar
MEDLINE
...
LILACS
LIS